Providence Health & Services - Oregon
Providence Health & Services - Oregon was paid $2.73M by Medicaid between Jan 2018 and Dec 2024, across 55 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 61% of everything it billed.
MEDFORD, OR 97501
Next to other Internal Medicine Physician providers in Oregon
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,047 | $503K | |
| 2019 | 10,887 | $690K | |
| 2020 | 9,905 | $596K | |
| 2021 | 10,274 | $584K | |
| 2022 | 12,123 | $144K | |
| 2023 | 14,206 | $115K | |
| 2024incomplete | 9,839 | $101K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 61% | 30,226 | 27,900 | $1.68M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 19,409 | 18,296 | $604K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.8% | 3,400 | 3,263 | $159K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.9% | 1,882 | 1,845 | $80K |
| 98928 | 1.8% | 1,172 | 967 | $50K | |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.1% | 507 | 381 | $30K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 460 | 428 | $24K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 666 | 658 | $13K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 669 | 641 | $12K |
| 99205 | Prolong outpt/office vis | <1% | 74 | 65 | $11K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 176 | 172 | $9K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,389 | 6,683 | $9K |
43 more codes
| 76881 | <1% | 131 | $7K | |
| 99442 | <1% | 103 | $6K | |
| 95886 | <1% | 49 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 397 | $4K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 33 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 568 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 148 | $3K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 112 | $3K |
| 80047 | <1% | 319 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 98 | $2K |
| 81003 | <1% | 1,695 | $2K | |
| 99443 | <1% | 32 | $2K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 15 | $2K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 21 | $1K |
| 71271 | <1% | 29 | $1K | |
| 76942 | <1% | 27 | $958.72 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 32 | $933.92 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 171 | $871.84 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13 | $820.20 |
| 81025 | <1% | 162 | $818.29 | |
| 80305 | <1% | 107 | $770.75 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 234 | $763.77 |
| 20610 | <1% | 21 | $602.78 | |
| 76882 | <1% | 14 | $589.51 | |
| 85027 | <1% | 136 | $479.94 | |
| 95874 | <1% | 18 | $458.10 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 18 | $377.44 |
| 90686 | <1% | 17 | $287.73 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 19 | $284.28 |
| 85610 | <1% | 186 | $249.56 | |
| 85014 | <1% | 128 | $167.74 | |
| 96127 | <1% | 14 | $103.20 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 95 | $78.89 |
| 81001 | <1% | 31 | $75.29 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12 | $64.59 |
| 81002 | <1% | 14 | $23.30 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 825 | $0.00 |
| 3079F | 0% | 345 | $0.00 | |
| 99000 | 0% | 1,064 | $0.00 | |
| 3074F | 0% | 1,548 | $0.00 | |
| H0049 | Alcohol and/or drug screening | 0% | 332 | $0.00 |
| 3075F | 0% | 65 | $0.00 | |
| 3078F | 0% | 853 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.